'Remarkable' Results With CAR T Cells Could Make Chemo Obsolete

Chemotherapy, the decades-old approach to second-line therapy for relapsed/refractory large B cell lymphomas, may soon be obsolete, investigators say.

Related Keywords

Colorado ,United States ,Florida ,Tampa ,Canada ,Vancouver ,British Columbia ,American ,Manali Kamdar ,Frederickl Locke ,Laurie Sehn ,American Society Of Hematology ,American Society Of Hematology Annual Meeting ,Bc Cancer Centre For Lymphoid ,University Of Colorado Cancer Center ,Moffitt Cancer Center ,Colorado Cancer Center ,Lymphoid Cancer ,New England Journal ,Medscape Medical News ,American Society ,Hematology Annual Meeting ,Non Hodgkins Lymphoma ,Chemotherapy ,Medical Conferences ,Professional Societies ,B Cell Lymphoma ,Hematology ,Cancer ,Alignant Neoplasia ,Arcinoma ,Biologic Therapy ,Chimeric Antigen Receptort Cell Therapy ,Chimeric Antigen Receptors ,Himeric Immunoreceptors ,Himerict Cell Receptors ,Rtificialt Cell Receptors ,Ar T ,Precision Medicine ,Refractory ,Diffuse Large Cell Lymphoma ,Neutropenia ,T Cell , ,Fire ,